GlassScriptPhysician profile
Maurice K Chung
NPI 1073505681
$3,630.21
in general payments reported to CMS, 2019-2025
20 companies · $852 in 2025
The $852 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,707 · 2020: $32.55 · 2021: $48.05 · 2022: $60.20 · 2023: $432 · 2024: $499 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513 · Travel and Lodging: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.40 |
| Travel and Lodging | $268.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis, INC | $1,500.00 | 2019 | |
| Medtronic, INC. | $1,185.06 | 2023-2025 | Interstim, Altaviva |
| Monaghan Medical Corporation | $164.37 | 2023 | Aeroeclipse |
| Caldera Medical, INC | $140.82 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $138.93 | 2025 | Exparel |
| Boston Scientific Corporation | $98.70 | 2019-2023 | |
| Astellas Pharma US INC | $61.54 | 2019-2020 | |
| Covidien LP | $60.00 | 2019 | |
| Abbvie INC. | $42.70 | 2019-2025 | |
| W. L. Gore & Associates, INC. | $36.85 | 2024 | Gore Synecor Biomaterial |
| Arthrex, INC. | $33.75 | 2021 | |
| Axonics, INC. | $29.35 | 2020-2021 | |
| Therapeuticsmd, INC. | $25.06 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.34 | 2023 | |
| Millicent US INC | $20.56 | 2025 | Femlyv, Intrarosa |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $16.01 | 2023 | Gemtesa |
| Allergan, INC. | $14.37 | 2019 | |
| Amgen INC. | $14.00 | 2019 | |
| Medtronic USA, INC. | $12.05 | 2019 | |
| Davol INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maurice Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.